Loading company…
Nebu~Flow develops nebulizer technology to deliver drugs precisely to the deep lung.
Nebu~Flow develops a nebulizer that uses surface acoustic waves to control droplet size and deliver drugs to the deep lung, including complex formulations and suspensions. Founded in 2019, the company is based in Glasgow, UK. In June 2026, it raised GBP 2 million in grant funding from Scottish Enterprise to finalize device design, test performance, and prepare regulatory submissions.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in